Peer-Reviewed Research Articles: GLP-1 Receptor Agonists for Weight Loss
PubMed articles specifically about using GLP-1 receptor agonists for weight loss. Vilsbøll T, Christensen M, Junker AE, Knop FK, Gluud LL. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ. 2012;344:d7771. doi: 10.1136/bmj.d7771. PMID: 22236411. Wadden TA, Hollander P, Klein S, et...
Read moreIn-Vitro Research: The Basics
In-vitro is a Latin term that means “in glass” and refers to experiments or studies that are performed outside of a living organism, such as in a test tube, petri dish, or other laboratory apparatus. In-vitro research typically involves the use of isolated cells or tissues, as well as...
Read moreNew GLP-1 Receptor Agonists Currently In Development
There are several new generations of GLP-1 receptor agonists that are currently in development and applying for FDA approval. These new drugs are designed to be more effective, longer lasting, and more convenient for patients compared to currently available GLP-1 receptor agonists. One of these new drugs is known as...
Read moreThe History of Semaglutide
Semaglutide is a GLP-1 receptor agonist medication that is currently used to treat type 2 diabetes mellitus. It was first approved by the US Food and Drug Administration (FDA) in December 2017, and has since been approved in other countries around the world. The development of semaglutide began in the...
Read moreUsing GLP-1 Receptor Agonists for Weight Loss
GLP-1 receptor agonists are a class of medications used to treat type 2 diabetes mellitus. However, they have also been found to be effective in promoting weight loss. The exact mechanism by which GLP-1 receptor agonists promote weight loss is not fully understood, but it is thought to be...
Read more